PAR 2.56% 20.0¢ paradigm biopharmaceuticals limited..

Paradigm Competition, page-13

  1. 1,080 Posts.
    lightbulb Created with Sketch. 269
    Also. I thinknthis is an older article but still worth a read


    https://pharmaphorum.com/news/and-then-there-were-none-regeneron-cans-last-late-stage-ngf-drug
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.